| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Aselage Steve is a Director at TVTX, with reported holdings spanning 2 companies. Recent filings cover 5 purchases and 42 sales. Those positions are worth an estimated $3.2M at current prices.
Our model assigns Aselage Steve a strong insider score of 80/100, based on 10 past trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +20.1%.
Aselage Steve's largest disclosed position is in TVTX as Director, worth about $3.2M. The recent filings there lean toward selling, a net 343,789 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 24, 2024 | BCRX Biocryst Pharmaceuticals Inc | Director | Buy | 2,500 | $6.40 | $16,000.00 | New | +29.4% | +72.8% | |
| May 11, 2022 | TVTX Travere Therapeutics, Inc. | Director | Sell | 2,575 | $21.92 | $56,456.62 | -1.7% | +30.5% | -24.4% | |
| Nov 16, 2021 | TVTX Travere Therapeutics, Inc. | Director | Sell | 31,800 | $29.39 | $934,602.00 | -17.5% | -5.0% | -28.2% | |
| Nov 5, 2021 | TVTX Travere Therapeutics, Inc. | Director | Sale+OE | 10,000 | $26.23 | $262,300.00 | -5.8% | -13.7% | -31.0% | |
| Nov 2, 2021 | TVTX Travere Therapeutics, Inc. | Director | Sell | 8,500 | $29.69 | $252,400.00 | -30.4% | -8.8% | -29.1% | |
| Oct 7, 2021 | TVTX Travere Therapeutics, Inc. | Director | Sale+OE | 60,000 | $26.25 | $1,574,760.00 | -24.0% | +12.6% | -5.1% | |
| May 11, 2021 | TVTX Travere Therapeutics, Inc. | Director | Sell | 2,146 | $19.58 | $42,022.97 | -1.1% | -28.4% | +7.8% | |
| Apr 16, 2021 | TVTX Travere Therapeutics, Inc. | Director | Sale+OE | 10,000 | $26.23 | $262,300.00 | -5.0% | -45.1% | +17.5% | |
| Mar 17, 2021 | TVTX Travere Therapeutics, Inc. | Director | Sale+OE | 17,727 | $27.44 | $486,456.12 | -8.6% | -46.4% | -11.5% | |
| Feb 2, 2021 | TVTX Travere Therapeutics, Inc. | Director | Sale+OE | 25,000 | $30.75 | $768,750.00 | -11.3% | - | - |